DNA X, Inc. (SONM) Revenue History
Annual and quarterly revenue from 2017 to present
SONM Revenue Over Time (2017–2025)
SONM Revenue Growth History
3 of 8 years with positive growth- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- +129.8%
- FY2019 revenue growth
- -14.3%
- FY2020 revenue growth
- -45.0%
- FY2021 revenue growth
- -14.7%
- FY2022 revenue growth
- +28.0%
- FY2023 revenue growth
- +34.1%
- FY2024 revenue growth
- -37.7%
- FY2025 revenue growth
- -100.0%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | -100.0% |
| Q4 2025 | $-44,125,000 | -394.5% |
| Q3 2025 | $16.2M | +7.9% |
| Q2 2025 | $11.2M | -2.8% |
| Q1 2025 | $16.7M | -0.3% |
| Q4 2024 | $15.0M | +11.6% |
| Q3 2024 | $15.0M | -45.5% |
| Q2 2024 | $11.5M | -57.1% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2024)
SONM's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
SONM Revenue Analysis (2017–2025)
Current Revenue & Growth
As of June 23, 2026, DNA X, Inc. (SONM) generated trailing twelve-month (TTM) revenue of $-16,721,000, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
SONM's historical revenue data shows various trends over time. DNA X, Inc.'s highest annual revenue of $135.7 million was recorded in 2018.
Revenue by Segment
SONM's revenue is primarily driven by Smartphones (52%), Feature Phones (40%), and Connected Solutions (7%). With over half of revenue concentrated in Smartphones, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Technology sector peers — including LIQT (+6.9% YoY), KOSS (+3.3% YoY), and NTGR (+2.8% YoY) — SONM has underperformed the peer group in revenue growth. Compare SONM vs LIQT →
SONM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SONMCurrent | $-16,721,000 | -100.0% | - | - | |
 LIQT | $17M | +6.9% | -6.0% | -50.3% | |
 KOSS | $13M | +3.3% | -7.2% | -13.8% | |
 NTGR | $693M | +2.8% | -11.2% | -5.1% | |
 SMSI | $17M | -12.5% | -19.5% | -110.8% | |
 GSAT | $273M | +11.5% | +16.3% | 5.4% |
SONM Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $-4,300,000 | - | $-5,406,000 | - |
| 2024 | $58.3M | -37.7% | $9.9M | 17.0% | $-33,639,000 | -57.7% |
| 2023 | $93.6M | +34.1% | $19.3M | 20.6% | $513K | 0.5% |
| 2022 | $69.8M | +28.0% | $11.6M | 16.6% | $-14,290,000 | -20.5% |
| 2021 | $54.6M | -14.7% | $6.4M | 11.8% | $-38,001,000 | -69.6% |
| 2020 | $64.0M | -45.0% | $15.2M | 23.8% | $-29,260,000 | -45.7% |
| 2019 | $116.3M | -14.3% | $34.5M | 29.7% | $-22,381,000 | -19.3% |
| 2018 | $135.7M | +129.8% | $48.1M | 35.4% | $5.4M | 4.0% |
| 2017 | $59.0M | - | $20.3M | 34.4% | $-6,770,000 | -11.5% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SONM — Frequently Asked Questions
Quick answers to the most common questions about buying SONM stock.
Is SONM's revenue growth accelerating or slowing?
SONM revenue is declining -100.0% year-over-year. TTM revenue fell to $-17M, contrasting with the 5-year CAGR of N/A. The reversal reflects either macro headwinds or company-specific challenges.
What is SONM's revenue history from 2017 to 2026?
DNA X, Inc. (SONM) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $-17M, growing at -100.0% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SONM's long-term revenue growth rate (CAGR)?
DNA X, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -100.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SONM.
Why does SONM's quarterly revenue fluctuate?
SONM quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. DNA X, Inc.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.
How is SONM's revenue distributed by segment?
SONM reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SONM's revenue compare to industry peers?
DNA X, Inc. (SONM) with TTM revenue of $-17M and -100.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.